The largest database of trusted experimental protocols

Fluorescence detector

Manufactured by Shimadzu
Sourced in Japan

The Fluorescence detector is a laboratory instrument used to measure the intensity of fluorescent light emitted from a sample. It provides a sensitive and selective method for the detection and quantification of fluorescent compounds. The core function of the Fluorescence detector is to excite the sample with a specific wavelength of light and then measure the emitted fluorescent light, which is proportional to the concentration of the fluorescent analyte present in the sample.

Automatically generated - may contain errors

12 protocols using fluorescence detector

1

HPLC-based Aflatoxin B1 Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
AFB1 quantification was carried out by a high-performance liquid chromatography (HPLC) coupled with a fluorescence detector (Shimadzu, Tokyo, Japan). Detection conditions were: excitation at 360 nm and emission at 440 nm. A Diamonsil® C18 reverse phase column (5 μm, 4.6 × 150 mm) was used for separation with the mobile phase consisting of water: methanol (45:55, v/v) at a flow rate of 1 mL min−1. The sample injection volume was 10 µL. The AFB1 standard samples were prepared in methanol with the concentration gradients (0, 6.25, 12.5, 25, 50, 75 and 100 ng mL−1) to establish the standard curve for AFB1 concentration calculation.
+ Open protocol
+ Expand
2

HPLC Analysis of Fluorescent Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HPLC (KNAUER Co, Germany), consisting of a C18 column and a fluorescence detector (Shimadzu, Japan) set at an excitation wavelength of 227 nm and an emission wavelength of 313 nm was used. Mobile phase A was acetonitrile, and mobile phase B was water. The system was run in a linear gradient: 0–6.0 min A 70%, B 30%; 6.0–6.2 min mobile phase A increased from 70 to 100% and continued to minute 12. The chromatographic analysis was performed at 25°C with a flow rate of 0.8 ml/min and an injection volume of 20 μl. Data collection was accomplished using EZChrom software and finally was statistically analyzed.
+ Open protocol
+ Expand
3

HPLC-FLD Quantification of Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Shimadzu HPLC system combined with fluorescence detector (Shimadzu Co., Kyoto, Japan) was used in this study. Chromatographic separation was conducted at 40 °C using a Kinetex C8 column (250 × 4.6 mm, 5 μm, 100 Å; Phenomenex, Torrance, CA, USA) protected by a C8 guard column (SecurityGuard HPLC Cartridge System, Phenomenex, Torrance, CA, USA). The gradient elution of the mobile phase consisting of pH 6.0 10 mM potassium phosphate buffer (Solvent A) and ACN (Solvent B) was performed at a flow rate of 1 mL/min as follows (solvent A:solvent B, v/v): maintained at 58:42 for 12.5 min; ramped from 58:42 to 50:50 for 0.5 min; maintained at 50:50 for 9 min; back to 58:42 for 0.5 min; and maintained for 3.5 min (total run time: 26 min).
+ Open protocol
+ Expand
4

Riboflavin Production by Bacillus velezensis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bacillus velezensis VTX9 was propagated in the LB medium at 37 °C overnight. The overnight culture was transferred to a new riboflavin production medium (yeast extract 4.0 g, fructose 38.1 g, MgSO 4 , 0.85 g, K 2 HPO 4 . 2.2 g, FeSO 4 0.02 g, pH 6.8-7.0 in a liter) and adjusted to an optical density at 600 nm of 0.1. At intervals, the culture was centrifuged at 4 °C, 10,000 rpm for 10 min to obtain the supernatant. Cell-free supernatant was used to determine riboflavin production. Quantification of riboflavin level was performed by using HPLC with a Fluorescence detector (Shimadzu, Japan) (Juarez del Valle et al. 2014) (link). Detection was conducted by a fluorescent detector. The excitation and emission wavelengths were 445 and 530 nm, respectively. Riboflavin was eluted in isocratic conditions using a mobile phase consisting of 0.05 M sodium acetate/methanol (30:70, v/ v). A standard curve was constructed with different dilutions of riboflavin.
+ Open protocol
+ Expand
5

Characterization of mGITR Oligomerization

Check if the same lab product or an alternative is used in the 5 most similar protocols
FSEC experiments were performed with either cell lysate or purified proteins. In all experiments, a high-performance liquid chromatography (HPLC) with autosampler (Shimadzu) was connected to a Superose 6 Increase 10/300 GL column (Cytiva) followed by a fluorescence detector (Shimadzu).
For lysate experiments, HEK293 cells expressing mGITR constructs fused to EGFP were resuspended in buffer containing 20 mM tris (pH 8.0), 300 mM NaCl, and 50 mM DDM and extracted at 4°C with gentle rocking for 1 hour. Lysate was clarified by ultracentrifugation before injecting into the HPLC running buffer containing 20 mM tris (pH 8.0), 300 mM NaCl, and 0.5 mM DDM. EGFP fluorescence was monitored using excitation and emission wavelengths of 488 and 509 nm, respectively.
For experiments with purified proteins, samples were run on the HPLC buffer containing 20 mM tris (pH 8.0), 300 mM NaCl, and 0.5 mM DDM. To monitor EGFP fluorescence, excitation and emission wavelengths of 488 and 509 nm were used, respectively. To monitor tryptophan fluorescence, excitation and emission wavelengths of 280 and 335 nm were used, respectively.
+ Open protocol
+ Expand
6

Characterization of Dipyridamole Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 2

High-performance liquid chromatography (HPLC) (fluorescence detector (Shimadzu, Japan)) was employed to analyze the Dipyridamole nanoparticles of the invention. The Dipyridamole nanoparticles were filtered with a 0.45 μm filter membrane to ensure that Dipyridamole is kept at a constant size so as to control the particle size that encapsulates the drug. The concentration of Dipyridamole before membrane filtration is designated as CTotal; the concentration of Dipyridamole after membrane filtration is designated as C. The formula for calculating the encapsulation rate (%) is C/CTotal×100%. The calculated encapsulation rate of the nanoparticles of PLGA-PEG-PLGA polymer and Dipyridamole is about 50%, wherein the content of Dipyridamole is about 2.0 mg/mL.

X Laser Particle Size Analyzer (Zetasizer, category no. 3000 HAS, Melven, UK) was employed to analyze the particle size distribution of the Dipyridamole nanoparticles of the invention. As shown in FIG. 3, the results show that the particle size is 155 nm and the polydispersity is 0.18, indicating that the particles are homogeneously distributed.

+ Open protocol
+ Expand
7

Quantifying Glutamate Levels in Traumatic Brain Injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glutamate concentration in TBI patients and controls were analyzed in 25 μL of the CSF cell‐free supernatant samples through high‐performance liquid chromatography (HPLC). Briefly, samples were filtered and derivatized with o‐phthalaldehyde and mercaptoethanol. CSF samples were separated by reverse phase column (Supelcosil LC‐18, 250 mm × 4.6 mm, Supelco) in a Shimadzu Instruments liquid chromatograph. The mobile phase flowed at a rate of 1.4 mL/min at 24°C. Buffer composition is A: 0.04 mol/L sodium dihydrogen phosphate monohydrate buffer, pH 5.5, containing 20% of methanol; and B: 0.01 mol/L sodium dihydrogen phosphate monohydrate buffer, pH 5.5, containing 80% of methanol. The gradient profile was modified according to the content of buffer B in the mobile phase: 0% at 0.00 min, 25% at 13.75 min, 100% at 15.00–20.00 min, and 0% at 20.01–25.00 min. Absorbance was read in a Shimadzu fluorescence detector, with excitation and emission being 360 nm and 455 nm, respectively. The concentration was expressed in μmol/L.22
+ Open protocol
+ Expand
8

Determination of Serum Amino Acids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Concentrations of serum amino acids, except tryptophan, were determined as previously described (Espe et al., 2014 (link)). In brief, serum samples were oxidized using a hydrogen peroxide solution (containing phenolic formic acid) at 0 °C for 16 h, and sodium pyrosulfite was added after the reaction to decompose the excess peroxyformic acid. Subsequently, 6 mol/L HCl solution was added to the oxidized samples and hydrolyzed at 110 °C for 23 h to release free amino acids. The concentrations of free amino acids were then determined on an amino acid analyzer (Biochrom, Version 30, Biochrom Ltd., Cambridge, UK) equipped with an ion-exchange column. Tryptophan was determined by a high-performance liquid chromatography (HPLC; Shimadzu, Tokyo, Japan). In brief, samples were saponified under alkaline conditions with barium hydroxide solution in the absence of air at 110 °C for 20 h in an autoclave. After adjusting the hydrolysate pH to 3.0, the tryptophan was separated by reversed-phase chromatography RP-18 on a HPLC column, and the chromatograms were integrated using Labsolutions software with a fluorescence detector (Shimadzu, Tokyo, Japan).
+ Open protocol
+ Expand
9

Glycosaminoglycan Oligosaccharide Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
An aliquot (2 μg) of CS was digested with CSase ABC (10 mIU) at 37 °C for 2 h in 50 mM Tris-HCl, 50 mM NaAc, PH 8.0. The digest was labeled with 2-AB [32 (link)] glycosaminoglycan-derived oligosaccharides labeled with a fluorophore 2-aminobeand subjected to anion-exchange HPLC on a YMC-Pack PA-G column eluted with a linear gradient from 16 to 474 mM NaH2PO4 over a period of 60 min being monitored at Ex 330 nm and Em 420 nm using a fluorescence detector (Shimadzu Co., Ltd., Kyoto, Japan) [30 (link)].
+ Open protocol
+ Expand
10

Disaccharide Characterization of Corneal Glycosaminoglycans

Check if the same lab product or an alternative is used in the 5 most similar protocols
The structural composition of CS/DS and HS/HEP was done via disaccharide characterization with strong anion chromatography (SAX) using high-pressure liquid chromatography (HPLC) at the Complex Carbohydrate Research Center (CCRC) at the University of Georgia (Supplementary Figures S1 and S2). Given the limited amount of material obtained from the mouse corneas, samples were subjected to a single instrumental run, as previously shown [124 (link),125 (link)]. Briefly, SAX-HPLC analysis was carried out using a 4.6 × 250 mm analytical column (Waters Spherisorb) with 5 μm particle size at 25 °C using an Agilent system. Disaccharides were eluted with a gradient from 97% of 2.5 mM sodium phosphate, pH 3.5 and 3% of 2.5 mM sodium phosphate, 1.2 M NaCl, pH 3.5 to 100% of 2.5 mM sodium phosphate, 1.2 M NaCl, pH 3.5 over a 55-min period at 1 mL/min. Disaccharides were detected by post-column derivatization by combining the eluent at a 1:1 ratio with 0.25 M NaOH and 1% 2-cyanoacetamide pumped at a flow rate of 0.5 mL/min from a binary HPLC pump. The mixture was heated to 120 °C in a 10-m reaction coil, cooled in a 50-cm cooling coil and directed into a Shimadzu fluorescence detector (λex = 346 nm, λem = 410). Elution profiles were compared to that of commercial standard disaccharides (Dextra Laboratories).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!